Key facts
- This page summarizes Jon Snodgres's Form 4 filing for REPLIGEN CORP (RGEN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Feb 2023, 15:56.
Jon Snodgres - 16 Feb 2023 Form 4 Insider Report for REPLIGEN CORP (RGEN)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RGEN
- Reported as of
- 16 Feb 2023
- Net transaction value
- -$1,129,400
- SEC form
- 4
- Accepted by SEC
- 17 Feb 2023, 15:56:31 UTC
- Prior SEC filing
- 11 Oct 2022
- Next SEC filing
- 01 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kimberly Brown (Attorney in Fact)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Jon Snodgres filed Form 4 for REPLIGEN CORP (RGEN) on 17 Feb 2023.
Change
- Previous filing in this sequence was filed on 11 Oct 2022.
- Current net transaction value: -$1,129,400.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RGEN
transaction
Common Stock
Sale
- Transaction value
- -$1,129,400
- Shares
- -5,647
- Change %
- -16%
- Price
- $200.00
- Shares after
- 29,325
- Date
- 16 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 06, 2022.